Close Window

Digital Look Email A Friend

Biogen to buy Pfizer schizophrenia drug for up to $590m

Published by Michele Maatouk on 12th March 2018

(ShareCast News) - Biogen has agreed to buy a phase 2b trial-ready schizophrenia treatment from Pfizer for up to $590m.

URL: http://www.digitallook.com/dl/news/story/27180445/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.